Evidence map›Paper›PMID 32034435›Full record

ReviewArchives of toxicology2020

Prospects and challenges of multi-omics data integration in toxicology.

Sebastian Canzler, Jana Schor, Wibke Busch, Kristin Schubert, Ulrike E Rolle-Kampczyk, Hervé Seitz, Hennicke Kamp, Martin von Bergen, Roland Buesen, Jörg Hackermüller

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Current approaches and advances in placental toxicology.Trends in endocrinology and metabolism: TEM · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sebastian Canzler *Helmholtz Centre for Environmental Research - UFZ, 04318, Leipzig, Germany.
Jana Schor *Helmholtz Centre for Environmental Research - UFZ, 04318, Leipzig, Germany.
Wibke BuschHelmholtz Centre for Environmental Research - UFZ, 04318, Leipzig, Germany.
Kristin SchubertHelmholtz Centre for Environmental Research - UFZ, 04318, Leipzig, Germany.
Ulrike E Rolle-KampczykHelmholtz Centre for Environmental Research - UFZ, 04318, Leipzig, Germany.
Hervé SeitzInstitut de Génétique Humaine UMR 9002 CNRS-Université de Montpellier, 34396, Montpellier Cedex 5, France.
Hennicke KampExperimental Toxicology and Ecology, BASF SE, 67056, Ludwigshafen, Germany.
Martin von BergenHelmholtz Centre for Environmental Research - UFZ, 04318, Leipzig, Germany.
Roland BuesenExperimental Toxicology and Ecology, BASF SE, 67056, Ludwigshafen, Germany.
Jörg HackermüllerHelmholtz Centre for Environmental Research - UFZ, 04318, Leipzig, Germany. joerg.hackermueller@ufz.de.ORCID http://orcid.org/0000-0003-4920-7072

Funding

European Chemical Industry Council Project C5-XomeTox
6 · The paper itself

Abstract

Exposure of cells or organisms to chemicals can trigger a series of effects at the regulatory pathway level, which involve changes of levels, interactions, and feedback loops of biomolecules of different types. A single-omics technique, e.g., transcriptomics, will detect biomolecules of one type and thus can only capture changes in a small subset of the biological cascade. Therefore, although applying single-omics analyses can lead to the identification of biomarkers for certain exposures, they cannot provide a systemic understanding of toxicity pathways or adverse outcome pathways. Integration of multiple omics data sets promises a substantial improvement in detecting this pathway response to a toxicant, by an increase of information as such and especially by a systemic understanding. Here, we report the findings of a thorough evaluation of the prospects and challenges of multi-omics data integration in toxicological research. We review the availability of such data, discuss options for experimental design, evaluate methods for integration and analysis of multi-omics data, discuss best practices, and identify knowledge gaps. Re-analyzing published data, we demonstrate that multi-omics data integration can considerably improve the confidence in detecting a pathway response. Finally, we argue that more data need to be generated from studies with a multi-omics-focused design, to define which omics layers contribute most to the identification of a pathway response to a toxicant.

Indexed as

AnimalsComputational BiologyGenomicsHumansMetabolomicsProtein Processing, Post-TranslationalProteomicsSingle-Cell AnalysisTissue DistributionToxicologyChemical exposureData integrationMulti-omicsRisk assessmentToxicology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.